The global hysteroscopy procedures market size is expected to reach USD 6.34 billion by 2028, registering a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Surge in prevalence of gynecological disorders, technological advancements, increasing adoption of minimally invasive surgeries, and favorable reimbursement policies are the key driving factors for the market. In addition, the impact of the COVID-19 pandemic has been significant on the market.
Key Insights & Findings:
- The hospitals end-use segment held the largest revenue share in 2020. The segment growth is credited to the high number of cases of gynecological disorders
- Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the presence of a large patient pool coupled with the rising aging population in the APAC region
- Integrating hysteroscopy into office practice will provide a lucrative opportunity for key market players. Several players have launched office hysteroscopy and associated devices
- For instance, Aveta System (office hysteroscopy), recently launched by Meditrina Inc. in March 2020, is an all-in-one tissue removal solution for intrauterine pathology, which offers wide-angle HD hysteroscopy
- Furthermore, in-office hysteroscopy is beneficial over traditional hysteroscopy procedures as it is efficient & clinically beneficial and offers a patient-centric approach
- It is also a simple and quick tool for retrieving intrauterine devices. Thus, physicians will consider investing in equipment and adopting an in-office approach for hysteroscopy.
Read 125 page market research report, “Hysteroscopy Procedures Market Size, Share & Trends Analysis Report By End Use (Ambulatory Surgical Centers, Hospitals, Clinics), By Region (Asia Pacific, Europe, North America), And Segment Forecasts, 2021 – 2028“, by Grand View Research
The pandemic has affected companies’ ability to develop and commercialize new & advanced products. Almost all companies are affected by reduced procedure volumes due to the pandemic, as all hospital resources are being diverted to fight the disease. Furthermore, the restrictions and functioning of a limited number of government offices are expected to delay clinical trials of products, which is expected to result in delayed product launches by companies.
The increasing prevalence of uterine fibroids is a key factor driving the market. For instance, as per the research article published in Dove Press Ltd., the prevalence of uterine fibroid disease ranges from 5.4% to 23.6%, depending upon the age group. Moreover, uterine fibroids can cause serious problems in 25% of women. Hysteroscopy is used to diagnose abnormalities, such as excessive bleeding, severe stomach cramps, recurrent miscarriages, or difficulties in conceiving. Thus, the presence of such a large patient pool leads to increased demand for hysteroscopy procedures.
Grand View Research has segmented the global hysteroscopy procedures market on the basis of end use and region:
- Hysteroscopy Procedures End-use Outlook (Revenue, USD Million, 2016 – 2028)
- Hospitals
- Clinics
- Ambulatory Surgery Centers (ASCs)
- Hysteroscopy Procedures Regional Outlook (Revenue, USD Million, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- MEA
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Qatar
- North America
List of Key Players of Hysteroscopy Procedures Market
- Medtronic
- Stryker Corp.
- Hologic, Inc.
- KARL STORZ SE & Co. KG
- Medical Devices Business Services, Inc. (Ethicon, Inc.)
- Olympus Corp.
- Delmont Imaging
- B. Braun Melsungen AG
- Richard Wolf GmbH
- CooperCompanies
- Maxer Endoscopy GmbH
- Boston Scientific Corp.
- MedGyn Products, Inc.
- Lina Medical APS
- Luminelle
- Meditrina, Inc. (Aveta).
Check out more studies related to uterine disorders and treatments, conducted by Grand View Research:
- Hysteroscope Market – The global hysteroscope market size was valued at USD 205.8 million in 2018 and is expected to grow at a CAGR of 5.0%. Increasing use of hysteroscopes for fertility examinations, checkup for abnormal uterine bleeding, & transcervical sterilizations are some key factors driving growth.
- Myomectomy Market – The global myomectomy market size was valued at USD 555.1 million in 2019 & is expected to grow at a CAGR of 9.1% from 2020 to 2027. Patients suffering from uterine fibroid problem represent a major factor.
Browse through Grand View Research’s coverage of the Global Medical Devices Industry.
